AORT
Artivion IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.60B
P/E Ratio
159.29
EPS
$0.21
Beta
1.62
52W High
$48.25
52W Low
$21.97
50-Day MA
$37.85
200-Day MA
$40.08
Dividend Yield
—
Profit Margin
2.21%
Forward P/E
55.56
PEG Ratio
643.75
About Artivion Inc
Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.
Fundamentals
| Revenue (TTM) | $441.33M |
| Gross Profit (TTM) | $284.23M |
| EBITDA | $53.80M |
| Operating Margin | 8.09% |
| Return on Equity | 2.70% |
| Return on Assets | 2.34% |
| Revenue/Share (TTM) | $9.73 |
| Book Value | $9.37 |
| Price-to-Book | 3.65 |
| Price-to-Sales (TTM) | 3.63 |
| EV/Revenue | 4.144 |
| EV/EBITDA | 28.66 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 19.20% |
| Shares Outstanding | $47.88M |
| Float | $45.37M |
| % Insiders | 4.52% |
| % Institutions | 90.98% |
Analyst Ratings
Consensus ($51.43 target)
2
Strong Buy4
Buy1
HoldData last updated: 4/7/2026